|
NXT2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.116800E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.324190E-01 |
| Normal-vs-Stage2 |
5.832200E-01 |
| Normal-vs-Stage3 |
7.610000E-01 |
| Normal-vs-Stage4 |
3.075600E-01 |
| Stage1-vs-Stage2 |
8.456000E-01 |
| Stage1-vs-Stage3 |
5.735200E-01 |
| Stage1-vs-Stage4 |
8.812400E-01 |
| Stage2-vs-Stage3 |
8.301400E-01 |
| Stage2-vs-Stage4 |
9.204200E-01 |
| Stage3-vs-Stage4 |
6.779000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.827400E-01 |
| Normal-vs-AfricanAmerican |
5.62949999949325E-08 |
| Normal-vs-Asian |
3.430400E-01 |
| Caucasian-vs-AfricanAmerican |
6.82440004506901E-09 |
| Caucasian-vs-Asian |
6.592200E-01 |
| AfricanAmerican-vs-Asian |
8.920100E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.666000E-01 |
| Normal-vs-Female |
3.068000E-02 |
| Male-vs-Female |
8.389900E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.419500E-03 |
| Normal-vs-Age(41-60Yrs) |
4.748000E-01 |
| Normal-vs-Age(61-80Yrs) |
3.328000E-01 |
| Normal-vs-Age(81-100Yrs) |
1.110950E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.472190E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.002000E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.897200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.196600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.707200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.342000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.886000E-01 |
| Normal-vs-Grade 2 |
7.777400E-01 |
| Normal-vs-Grade 3 |
1.803250E-01 |
| Normal-vs-Grade 4 |
4.884100E-02 |
| Grade 1-vs-Grade 2 |
4.951200E-01 |
| Grade 1-vs-Grade 3 |
9.180000E-01 |
| Grade 1-vs-Grade 4 |
7.182200E-01 |
| Grade 2-vs-Grade 3 |
3.500600E-01 |
| Grade 2-vs-Grade 4 |
1.042230E-01 |
| Grade 3-vs-Grade 4 |
3.560400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
6.291800E-01 |
| Normal-vs-ccB subtype |
2.772200E-01 |
| ccA subtype-vs-ccB subtype |
1.333010E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.887400E-01 |
| Normal-vs-N1 |
1.271440E-01 |
| N0-vs-N1 |
2.952200E-01 |
|
|
